How Redlen is Revolutionizing CT Therapy

Glenn Bindley speaks at a podium with a microphone attached to his collar. The background features blue and white tones, likely from a stage setup.
Events

How Redlen is Revolutionizing CT Therapy

When:
Where: On Demand Webinar
Time:

From Scrappy Startup to Trailblazer: How Redlen is Revolutionizing CT Therapy” is now available as an on demand webinar. Featuring Jim Balcom and Glenn Bindley, this webinar explores the remarkable journey of Redlen Technologies Inc., a startup that evolved into a global leader in CT imaging innovation.

The story began over two decades ago with an ambitious vision: to revolutionize the radiation imaging industry. Jim and Glenn recount how the company harnessed the power of cadmium zinc telluride (CZT) crystal technology to create imaging solutions that set new standards in clarity and efficiency.

They detail the ingenuity required to refine their processes, scale production, and overcome technical and financial challenges. This webinar provides a front-row seat to the strategies and determination that helped Redlen break barriers and transform the CT imaging market.

A highlight is the discussion around Redlen’s groundbreaking work in developing superior CZT crystals. These crystals offered unparalleled imaging quality at room temperature, eliminating the need for cryogenic systems. Jim and Glenn shared how this innovation unlocked opportunities in medical, security, and industrial imaging markets, positioning the company as a trailblazer in a $2 billion industry. The journey culminated in a strategic acquisition by Canon Inc., valued at over $400 million—a testament to the transformative potential of Redlen’s technology and vision.

The webinar offers an insider’s look at the acquisition process, shedding light on the strategic decisions that helped Redlen stand out as an indispensable partner to Canon. Their candid reflections on the challenges and rewards of navigating the competitive medtech landscape offer invaluable lessons for entrepreneurs and innovators.

The webinar is ideal for anyone interested in the intersection of cutting-edge innovation, strategic growth, and successful exits in the medtech industry.

From Scrappy Startup to Trailblazer

How Redlen is Revolutionizing CT Therapy

Presenter Bios:

Headshot of Glenn Bindley

Glenn Bindley

President & CEO
Redlen Technologies

Glenn is an Electrical Engineer and MBA who brings over 25 years of design, product marketing, business development and executive management experience in the semiconductor industry. He was a founder of PMC-Sierra, Inc. and grew a highly profitable division with sales exceeding $200M per year. Glenn is a holder of 6 semiconductor device patents and has extensive experience in product marketing, building strategic business relationships, and successfully managing high growth businesses.

Headshot of Jim Balcom

Jim Balcom

Chief Operating Officer
Redlen Technologies

Jim Balcom has spent his career in the technology industry in Silicon Valley, Seattle, Vancouver and Victoria. Most recently, Jim was COO of Redlen Technologies where he helped develop world-leading medical and security imaging technology and products, attracting talent and customers from around the world to grow the team and revenues, ultimately culminating in a successful exit to Canon Inc. of Japan in one of BC’s major technology success stories.

Medical Device Playbook is one of North America’s largest MedTech events for entrepreneurial companies and medical device professionals. Designed to inform and inspire medtech and biotech entrepreneurs, Playbook brings you stories and insights from some of the industry’s most remarkable entrepreneurs and seasoned experts.

StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics.

StarFish Medical’s technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client’s site, and assisting with ISO 13485 certification audits.

Empowering MedTech Innovation®. www.starfishmedical.com

Contact Patrick Dean, Director of Marketing, for media inquiries.